Genetic polymorphism of <i>SLC31A1</i> is associated with clinical outcomes of platinum-based chemotherapy in non-small-cell lung cancer patients through modulating microRNA-mediated regulation.

Oncotarget · 2018 · PMC5963629 · PMID 29844858

Europe PMC DOI

hedged sentence

0.0630

closest p · 1.3× alpha

0.0630

boldest claim

The sentences

marginal significanceP = 0.063so close (0.05 < p ≤ 0.1)

Interestingly, we observed that rs4979223 ( P = 0.007), rs4978536 ( P = 0.063, with marginal significance), rs2233914 ( P = 0.039), rs10817464 ( P = 0.006) and rs10759637 ( P = 0.006) showed significantly divergent genotypic distribution between groups with mild or severe thrombocytopenia, some of which remained statistically significant after multiple test correction.

also in 3,507 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.